Published in Arch Surg on April 01, 1998
Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol (2008) 2.02
Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ (2001) 1.86
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest (2003) 1.84
Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging. Arch Phys Med Rehabil (2011) 1.40
Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia. Health Econ Rev (2016) 1.39
Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express (2010) 1.31
Could Kinesio tape replace the bandage in decongestive lymphatic therapy for breast-cancer-related lymphedema? A pilot study. Support Care Cancer (2009) 1.31
Directions and dilemmas in massage therapy research: a workshop report from the 2009 north american research conference on complementary and integrative medicine. Int J Ther Massage Bodywork (2009) 1.11
Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther (2011) 1.08
Near-infrared fluorescence imaging of lymphatics in head and neck lymphedema. Head Neck (2010) 1.08
Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. Support Care Cancer (2010) 1.05
Effectiveness of the treatment-phase of two-phase complex decongestive physiotherapy for the treatment of extremity lymphedema. Int J Clin Oncol (2007) 1.00
A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]. BMC Cancer (2006) 1.00
Lymphedema and therapeutic lymphangiogenesis. Biomed Res Int (2013) 0.97
Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study. Support Care Cancer (2009) 0.92
Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. World J Surg Oncol (2013) 0.91
Clinical outcomes of extracorporeal shock wave therapy in patients with secondary lymphedema: a pilot study. Ann Rehabil Med (2013) 0.89
Quality of life, upper extremity function and the effect of lymphedema treatment in breast cancer related lymphedema patients. Ann Rehabil Med (2012) 0.86
A comprehensive review of head and neck cancer rehabilitation: physical therapy perspectives. Indian J Palliat Care (2012) 0.85
G protein-coupled receptors as potential drug targets for lymphangiogenesis and lymphatic vascular diseases. Arterioscler Thromb Vasc Biol (2009) 0.85
Lymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging. Biomed Opt Express (2012) 0.83
Long-term effects of complex decongestive therapy in breast cancer patients with arm lymphedema after axillary dissection. Ann Rehabil Med (2013) 0.82
Cold and compression in the management of musculoskeletal injuries and orthopedic operative procedures: a narrative review. Open Access J Sports Med (2010) 0.82
Can ICF model for patients with breast-cancer-related lymphedema predict quality of life? Support Care Cancer (2010) 0.80
Design and development of a telerehabilitation self-management program for persons with chronic lower limb swelling and mobility limitations: preliminary evidence. Nurs Res Pract (2012) 0.80
Retrospective trial of complete decongestive physical therapy for lower extremity secondary lymphedema in melanoma patients. Support Care Cancer (2010) 0.79
Teaching self-management skills in persons with chronic lower limb swelling and limited mobility: evidence for usability of telerehabilitation. Int J Telerehabil (2013) 0.79
Twisting Tourniquet(©) Technique: introducing Schnogh, a novel device and its effectiveness in treating primary and secondary lymphedema of extremities. Cancer Med (2015) 0.75
The effect of combined decongestive therapy and pneumatic compression pump on lymphedema indicators in patients with breast cancer related lymphedema. Iran Red Crescent Med J (2012) 0.75
Unilateral upper extremity lymphedema deteriorates the postural stability in breast cancer survivors. Contemp Oncol (Pozn) (2014) 0.75
Long-term results of microscopic lymphatic vessel-isolated vein anastomosis for secondary lymphedema of the lower extremities. Surg Today (2006) 0.75
Impact of aggressive decongestion on the maintenance phase in combined physical therapy for lower extremity lymphedema. Ann Vasc Dis (2011) 0.75
Topical bFGF Improves Secondary Lymphedema through Lymphangiogenesis in a Rat Tail Model. Plast Reconstr Surg Glob Open (2014) 0.75
A multimodal physical therapy approach to the management of a patient with temporomandibular dysfunction and head and neck lymphedema: a case report. J Man Manip Ther (2015) 0.75
Development of mHealth system for supporting self-management and remote consultation of skincare. BMC Med Inform Decis Mak (2015) 0.75
Effects of simplified lymph drainage on the body: in females with menopausal disorder. J Phys Ther Sci (2017) 0.75
Recent advances in medical treatment for lymphedema. Ann Vasc Dis (2012) 0.75
Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells. J Ethnopharmacol (2016) 0.75
A prospective randomised study of alginate-drenched low stretch bandages as an alternative to conventional lymphologic compression bandaging. Support Care Cancer (2009) 0.75
Breast cancer survivors' perspectives of critical lymphedema self-care support needs. Support Care Cancer (2016) 0.75
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18
An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets. Br J Haematol (1991) 2.74
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med (2000) 2.61
Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Proc Natl Acad Sci U S A (1984) 2.40
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A (1998) 2.29
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22
Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation (1999) 2.16
American Cancer Society Lymphedema Workshop. Workgroup III: Diagnosis and management of lymphedema. Cancer (1998) 2.06
Native portal vein embolization for persistent hyperoxaluria following kidney and auxiliary partial liver transplantation. Am J Transplant (2013) 2.05
BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins. Proc Natl Acad Sci U S A (1988) 1.91
Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant (2010) 1.84
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol (1999) 1.77
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77
BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation (2001) 1.75
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer (1997) 1.71
Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation (1999) 1.66
Dynamic properties of water at phosphatidylcholine lipid-bilayer surfaces as seen by deuterium and pulsed field gradient proton NMR. Chem Phys Lipids (1994) 1.66
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation (1998) 1.57
Tolerance in a concordant nonhuman primate model. Transplantation (1999) 1.53
A mutation altering the function of a carbohydrate binding protein blocks cell-cell cohesion in developing Dictyostelium discoideum. Nature (1979) 1.53
Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant (2007) 1.51
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant (2014) 1.49
Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49
Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen. EMBO J (1985) 1.48
Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl (2001) 1.46
Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation (1997) 1.45
Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Am J Transplant (2014) 1.44
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation (2001) 1.44
Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40
[Cost-effectiveness of atorvastatin for the prevention of coronary disease. An analysis of the ASCOT study]. Dtsch Med Wochenschr (2004) 1.40
Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant (2010) 1.39
Spinal aspergillus abscess in a patient with bronchocentric granulomatosis. J Intensive Care Med (1995) 1.39
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant (2011) 1.38
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation (2001) 1.38
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Plasma interleukin 2 receptor levels in renal allograft recipients. Clin Immunol Immunopathol (1987) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Hyperparathyroidism during pregnancy. Am J Surg (1976) 1.29
B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant (2009) 1.27
Immunosuppression and temporary skin transplantation in the treatment of massive third degree burns. Ann Surg (1975) 1.26
Infection in the renal transplant recipient. Am J Med (1981) 1.25
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg (1982) 1.24
Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation (1986) 1.24
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation (1984) 1.20
Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant (2011) 1.20
Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med (1983) 1.18
Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation (1981) 1.18
Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant (2011) 1.17
Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease. Gastroenterology (1985) 1.17
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation (1992) 1.16
Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. Transplant Proc (1994) 1.15
Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer (1999) 1.15
Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma. Clin Immunol Immunopathol (1976) 1.15
A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci U S A (1989) 1.13
Liver transplantation for primary hepatic cancer. Transplantation (1992) 1.13
Heparin in the treatment of hypofibrinogenemia complicating fetal death in utero. Am J Obstet Gynecol (1967) 1.11
Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant (2008) 1.11
Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses. Transplant Proc (1981) 1.11
Recurrence of glomerulonephritis in the transplanted kidney. Arch Intern Med (1969) 1.10
A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation (1993) 1.10
Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation (1998) 1.09
Cynomolgus polyoma virus infection: a new member of the polyoma virus family causes interstitial nephritis, ureteritis, and enteritis in immunosuppressed cynomolgus monkeys. Am J Pathol (1999) 1.08
Strain-specific markers for the major structural proteins of highly oncogenic murine mammary tumor viruses by tryptic peptide analyses. J Virol (1978) 1.08
A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplantation (1987) 1.07
Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia. J Lipid Res (1976) 1.07
Antigenic polymorphism of the T4 differentiation antigen expressed on human T helper/inducer lymphocytes. Hum Immunol (1984) 1.06
Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation (1999) 1.06
Clinical development of Orthoclone OKT3. Transplant Proc (1987) 1.05
De novo collapsing glomerulopathy in renal allografts. Transplantation (1998) 1.05
Viruses and thrombotic microangiopathy. Transplantation (1999) 1.05
The effect of infection on T lymphocyte subpopulations: a preliminary report. Int J Immunopharmacol (1981) 1.04
Idiopathic giant esophageal ulcers in a renal transplant patient responsive to steroid therapy. Transplantation (2000) 1.03
Effect of immunosuppressive therapy for renal allografts on the number of circulating sheep red blood cells rosetting cells. Transplantation (1975) 1.02
Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation (1982) 1.01
Cardiovascular complications following liver transplantation. Clin Transplant (1995) 1.01
The renal transplant patient with fever and pulmonary infiltrates: etiology, clinical manifestations, and management. Medicine (Baltimore) (1980) 1.01
Hepatic retransplantation in New England--a regional experience and survival model. Transplantation (1993) 1.01
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. Am J Surg (1981) 1.01
Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg (1999) 1.00
Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol (2000) 1.00
Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. Surgery (1976) 1.00
Signal transduction mechanisms for leukotriene B4 induced hyperadhesiveness of endothelial cells for neutrophils. J Immunol (1994) 0.99
Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation (1998) 0.99
Transplantation. N Engl J Med (1979) 0.98
Cellular immune competence of breast cancer patients receiving radiotherapy. Arch Surg (1973) 0.98
Use of antithymocyte globulin for reversal of acute allograft rejection. Transplantation (1979) 0.98
Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors. Clin Exp Immunol (1985) 0.98
Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med (1977) 0.98
Corynebacterium group JK in a hematological ward: infections, colonization and environmental contamination. Scand J Infect Dis (1988) 0.97
Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol (1999) 0.97
Membrane/water partition of oligo(ethylene oxide) dodecyl ethers and its relevance for solubilization. Biochim Biophys Acta (1994) 0.97